A record of what Shashank Krishnakumar said publicly, with the source. Not advice.
EG
Shashank Krishnakumar
Track record
Building a track record
Graded calls
0 hit · 0 miss
Pending
0 awaiting resolution
Scored on trackable calls only. Long-horizon and commentary opinions are listed below but not counted in this score.
Recent calls
Newest first. Every call links back to its original source.
| Call | Instrument | Verdict | Actions |
|---|---|---|---|
| “Bullish on Sun Pharma, retaining a 'Buy' rating with a target price of ₹2,250 for March 2026. Q4FY25 EBITDA was in line …” | Sun Pharmaceutical Industries Ltd. | MISS |
By instrument
Graded calls broken down by what was being called.
Sun Pharmaceutical Industries Ltd.
0 hit · 1 miss